Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

BIZARRE: 2 - You Need To See This

Palantir Short Seller Andrew Left's Citron Now Compares It To Databricks: 'PLTR Is A $40 Stock, And Every Real AI Leader Keeps Reminding Us'

Short-seller Andrew Left‘s Citron Research intensified its campaign against Palantir Technologies Inc. (NYSE:PLTR) on Wednesday, posting a direct comparison to private competitor Databricks that highlights Palantir’s slower growth on several key metrics.

Benzinga

Palantir Continues To Decline In Pre-Market As Valuation Concerns Mount—Citron Research Targets Overvaluation

Palantir Technologies Inc. (NASDAQ:PLTR) declined 0.95% to $156.08 during pre-market on Wednesday, extending its 9.35% drop from Tuesday's regular trading, despite expanding its partnership with Fujitsu Ltd.

Benzinga

Short Seller Andrew Left Says 'OpenAI At $500 Billion Puts Palantir At $40' — And That's Generous

Renowned short-seller Andrew Left's Citron Research has issued a bearish report on Palantir Technologies Inc. (NASDAQ:PLTR), arguing the stock is significantly overvalued and its price is "detached from fundamentals and analysis".

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Citron Research Just Warned AGAIN on Palantir. How Should You Play PLTR Stock Here?

Citron Research says Palantir stock at $40 per share would still be an expensive AI stock to own. Wall Street recommends caution on PLTR shares as well.

Barchart

What's Going On With Palantir Technologies (PLTR) Stock?

Palantir Technologies Inc (NASDAQ:PLTR) shares have become a focal point of market debate in recent sessions as a new short-seller report clashes with bullish catalysts from government and enterprise sectors. Here’s what investors need to know.

Benzinga

GameStop Short Seller Bets Against Palantir — Goes Long UnitedHealth Alongside Buffett, Burry

UnitedHealth Group (NYSE:UNH) stock is soaring Friday morning with a handful of large investors revealing long positions in the health insurance company via quarterly 13F filings.

Benzinga

Short Seller Slams Jim Cramer Over Palantir, Accuses Him Of Hyping 'High-Multiple, Hype-Driven Narrative' After $200 Price Target Call

Famed short-seller Andrew Left's Citron Research publicly challenged CNBC's Jim Cramer over his bullish stance on Palantir Technologies Inc. (NASDAQ:PLTR).

Benzinga

Read news from The Economist, FT, and more,
with one subscription

GameStop Short Seller Andrew Left Is Taking On Retail Investors Again, Now Says Palantir Stock Is 'Beyond Overvalued'

Citron Research founder and famed short seller Andrew Left announced a new short pick on Wednesday during an appearance on Fox Business.

Benzinga

Andrew Left Doubles Down On Rocket Companies: 'This Isn't A Meme,' It's A 'Housing Juggernaut' In The Making (CORRECTED)

Editor's Note: This article has been updated to correct the individual’s name in the headline.

Benzinga

My air fryer dessert hack is on sale – these tiny Staub cocottes are the trick to the easiest single-serve sweet treats

My favorite purchase of the year is now discounted at Nordstrom

Homes & Gardens

Color me shocked — The Galaxy Z Fold 7 is an absolute beast for gaming

Something that makes a foldable phone so special is its versatility. Usually, we focus on productivity, but today, we're taking a look at the gaming versatility of the Galaxy Z Fold 7.

Android Central

Teladoc Stock Is a ‘Coiled Spring’ That Could Surge Higher. Should You Buy TDOC Here?

Teladoc stock gains as Citron Research posts a bullish report in its favor. Wall Street remains positive on TDOC shares for the second half of 2025 as well.

Barchart

Teladoc Health Stock Jumps After Citron Research Calls It A 'Coiled Spring'

Teladoc Health Inc (NYSE:TDOC) shares are rising Monday after Citron Research made positive comments about the company on its X account.

Benzinga

Citron Research Just Identified This 1 Stock to Buy as a ‘Hidden’ AI Winner

Former short seller Citron Research is growing bullish on Teladoc's growth potential.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Nebius Group (NBIS): A Small-Cap Backed by NVIDIA

Nebius Group (NASDAQ: NBIS), a Netherlands-based AI technology company, has drawn increased attention recently due to NVIDIA’s (NASDAQ: NVDA) backing.

MarketBeat

Nebius Group Stock: A Rising AI Infrastructure Star

Nebius Group (NASDAQ: NBIS) has surged 45% in a week, driven by a $700 million private placement with major investors, including NVIDIA.

Benzinga

Andrew Left's Citron Research Says Nvidia-Backed Nebius Is The Next 'AI Wall Street Darling' — Stock Moves Up 14%

Shares of Nebius Group NV (NASDAQ:NBIS) jumped 13.90% on Tuesday after Citron Research highlighted the company’s potential to become the next artificial intelligence sensation on Wall Street, citing its deep ties with NVIDIA Corp. (NASDAQ:

Homes & Gardens

Should you clean every day? Pro house cleaners reckon it will limit stress but here's how to avoid the pitfalls

Learn which things to clean daily and what to leave for a bigger cleaning task

Get all your
news in one place.

100's of premium titles.
One news app.

Top News

Short Seller Andrew Left Charged With Securities Fraud Scheme

Short seller Andrew Left charged with securities fraud for manipulating stock prices through Citron Research. SEC also pursuing charges in a million fr...

Fortune

GameStop pockets record $2.1 billion from snap share sale that tanked the stock

And GameStop has Roaring Kitty, a.k.a. Keith Gill, to thank for it.

Zenger

Apple, Lions Gate Join IBM In Pushback Against Elon Musk, Twitter Over Antisemitic Content

World's richest person is also most followed person on a leading social media platform,when they post or reply,it is widely seen

Benzinga

Why This Short Seller Is Doubling Down Against Cryptocurrency, Says 'US Government Should Be Embarrassed' About FTX Debacle

Activist investor and short seller Citron Research made headlines in 2021 for attacking stocks like GameStop Corporation (NYSE: GME) and other popular companies with the retail investment crowd.

Benzinga

Citron Research Targets Bitcoin, Ethereum, NFTs After Staying On Sidelines For 18 Months

A well-known figure from the David vs. Goliath story involving video game retailer GameStop Corp (NYSE: GME) that pitted retail traders against hedge funds and short-sellers has sights set on the cryptocurrency investors.

Benzinga

'Diamond Hands: The Legend Of WallStreetBets' Dives Into GameStop & AMC Squeeze: Here's What To Know About The Film's Premiere

MSNBC Films, NBC News Studios, and ZCDC Films will premiere “Diamond Hands: The Legend of WallStreetBets” Sunday, May 15 at 10 p.m. EDT on MSNBC. What To Know: The documentary launch comes more than a year after retail traders on online forums like WallStreetBets clashed with famed fundamentalists like Citron…

Birmingham Post

Citron Hygiene signs 5-year deal on new Leicestershire HQ

It provides managed services such as sharps bins, sanitary waste, hand dryers, paper dispensers and facilities management

1 2 3

People

Vanessa Terra Bossart

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.